Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy

scientific article

Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/MC.22040
P698PubMed publication ID23661548

P2093author name stringJian Wu
Xiang Chen
Feng Gao
Wei Xu
Haiyang Xie
Liming Wu
Lin Zhou
Shusen Zheng
Qing Xie
Jun Cheng
Zhen Lv
Chunyang Xing
Sunyi Ye
P433issue10
P921main subjecthypoxiaQ105688
hepatocellular carcinomaQ1148337
P304page(s)820-832
P577publication date2013-05-09
P1433published inMolecular CarcinogenesisQ15724597
P1476titleProhibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy
P478volume53

Reverse relations

cites work (P2860)
Q58762210A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
Q58785789Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Q60929868Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
Q35116051Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma
Q35750767Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer
Q37625410Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity
Q60927782Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
Q49450301Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells
Q36804624Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer
Q47729926Proteomic analysis of mitochondria: biological and clinical progresses in cancer
Q55253157Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
Q55295932Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.

Search more.